Published in Proc Natl Acad Sci U S A on September 07, 2004
Cell type-specific gene expression of midbrain dopaminergic neurons reveals molecules involved in their vulnerability and protection. Hum Mol Genet (2005) 2.28
Neurotoxicity and metabolism of the catecholamine-derived 3,4-dihydroxyphenylacetaldehyde and 3,4-dihydroxyphenylglycolaldehyde: the role of aldehyde dehydrogenase. Pharmacol Rev (2007) 1.72
Unexpected expression of alpha- and beta-globin in mesencephalic dopaminergic neurons and glial cells. Proc Natl Acad Sci U S A (2009) 1.64
Spatiotemporally separable Shh domains in the midbrain define distinct dopaminergic progenitor pools. Proc Natl Acad Sci U S A (2009) 1.37
Defining midbrain dopaminergic neuron diversity by single-cell gene expression profiling. Cell Rep (2014) 1.11
Improved RNA preservation for immunolabeling and laser microdissection. RNA (2009) 1.02
Gene expression profiles of brain dopamine neurons and relevance to neuropsychiatric disease. J Physiol (2006) 1.00
An endogenous serine/threonine protein phosphatase inhibitor, G-substrate, reduces vulnerability in models of Parkinson's disease. J Neurosci (2007) 0.98
Identification and distribution of projections from monoaminergic and cholinergic nuclei to functionally differentiated subregions of prefrontal cortex. Brain Res (2013) 0.98
Functional significance of aldehyde dehydrogenase ALDH1A1 to the nigrostriatal dopamine system. Brain Res (2011) 0.94
Molecular determinants of selective dopaminergic vulnerability in Parkinson's disease: an update. Front Neuroanat (2014) 0.90
Brain expression quantitative trait locus mapping informs genetic studies of psychiatric diseases. Neurosci Bull (2011) 0.90
Functional enhancement and protection of dopaminergic terminals by RAB3B overexpression. Proc Natl Acad Sci U S A (2009) 0.89
"NeuroStem Chip": a novel highly specialized tool to study neural differentiation pathways in human stem cells. BMC Genomics (2007) 0.88
Loss of PINK1 attenuates HIF-1α induction by preventing 4E-BP1-dependent switch in protein translation under hypoxia. J Neurosci (2014) 0.87
The lifelong maintenance of mesencephalic dopaminergic neurons by Nurr1 and engrailed. J Biomed Sci (2014) 0.87
New perspectives on catecholaminergic regulation of executive circuits: evidence for independent modulation of prefrontal functions by midbrain dopaminergic and noradrenergic neurons. Front Neural Circuits (2014) 0.87
Rgs6 is required for adult maintenance of dopaminergic neurons in the ventral substantia nigra. PLoS Genet (2014) 0.84
Molecular marker differences relate to developmental position and subsets of mesodiencephalic dopaminergic neurons. PLoS One (2013) 0.84
Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains. J Physiol (2015) 0.84
Genetic dissection of midbrain dopamine neuron development in vivo. Dev Biol (2012) 0.83
Purity and enrichment of laser-microdissected midbrain dopamine neurons. Biomed Res Int (2013) 0.83
Identification of neurodegenerative factors using translatome-regulatory network analysis. Nat Neurosci (2015) 0.82
Strategies to unravel molecular codes essential for the development of meso-diencephalic dopaminergic neurons. J Physiol (2006) 0.82
Widespread increases in malondialdehyde immunoreactivity in dopamine-rich and dopamine-poor regions of rat brain following multiple, high doses of methamphetamine. Front Syst Neurosci (2011) 0.80
Analysis of the Catecholaminergic Phenotype in Human SH-SY5Y and BE(2)-M17 Neuroblastoma Cell Lines upon Differentiation. PLoS One (2015) 0.80
The SH-SY5Y cell line in Parkinson's disease research: a systematic review. Mol Neurodegener (2017) 0.79
Proteomics of the human brain: sub-proteomes might hold the key to handle brain complexity. J Neural Transm (Vienna) (2006) 0.79
Linkage of cDNA expression profiles of mesencephalic dopaminergic neurons to a genome-wide in situ hybridization database. Mol Neurodegener (2009) 0.79
Parkinson's disease candidate gene prioritization based on expression profile of midbrain dopaminergic neurons. J Biomed Sci (2010) 0.78
Molecular heterogeneity of midbrain dopaminergic neurons - Moving toward single cell resolution. FEBS Lett (2015) 0.78
Biochemical premotor biomarkers for Parkinson's disease. Mov Disord (2012) 0.78
Evidence for a specialized role of the locus coeruleus noradrenergic system in cortical circuitries and behavioral operations. Brain Res (2015) 0.77
Diversity matters - heterogeneity of dopaminergic neurons in the ventral mesencephalon and its relation to Parkinson's Disease. J Neurochem (2016) 0.77
Mesencephalic dopaminergic neurons express a repertoire of olfactory receptors and respond to odorant-like molecules. BMC Genomics (2014) 0.77
Mapping dopaminergic deficiencies in the substantia nigra/ventral tegmental area in schizophrenia. Brain Struct Funct (2014) 0.77
Midbrain Gene Screening Identifies a New Mesoaccumbal Glutamatergic Pathway and a Marker for Dopamine Cells Neuroprotected in Parkinson's Disease. Sci Rep (2016) 0.76
CellMapper: rapid and accurate inference of gene expression in difficult-to-isolate cell types. Genome Biol (2016) 0.76
Neuroprotective therapy in Parkinson's disease: current status and new directions from experimental and genetic clues. J Clin Neurol (2005) 0.75
Survival of a Novel Subset of Midbrain Dopaminergic Neurons Projecting to the Lateral Septum Is Dependent on NeuroD Proteins. J Neurosci (2017) 0.75
Antioxidant and tyrosinase inhibition activity of the fertile fronds and rhizomes of three different Drynaria species. BMC Res Notes (2015) 0.75
Opposite initialization to novel cues in dopamine signaling in ventral and posterior striatum in mice. Elife (2017) 0.75
The Hyperpolarization-Activated Current Determines Synaptic Excitability, Calcium Activity and Specific Viability of Substantia Nigra Dopaminergic Neurons. Front Cell Neurosci (2017) 0.75
Pitx3 and En1 determine the size and molecular programming of the dopaminergic neuronal pool. PLoS One (2017) 0.75
Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97
Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A (2001) 132.88
Parkinson's disease: mechanisms and models. Neuron (2003) 14.84
Amplified RNA synthesized from limited quantities of heterogeneous cDNA. Proc Natl Acad Sci U S A (1990) 11.10
Neurobiology of depression. Neuron (2002) 8.56
Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain (1991) 8.16
Molecular pathways of neurodegeneration in Parkinson's disease. Science (2003) 7.55
The T/ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev (1996) 5.71
Schizophrenia as a disorder of neurodevelopment. Annu Rev Neurosci (2002) 4.36
Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans. Nat Genet (2002) 4.01
EVIDENCE FOR THE EXISTENCE OF MONOAMINE-CONTAINING NEURONS IN THE CENTRAL NERVOUS SYSTEM. I. DEMONSTRATION OF MONOAMINES IN THE CELL BODIES OF BRAIN STEM NEURONS. Acta Physiol Scand Suppl (1964) 3.57
FGF and Shh signals control dopaminergic and serotonergic cell fate in the anterior neural plate. Cell (1998) 3.33
Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci (2003) 3.15
The neurobiology of sleep: genetics, cellular physiology and subcortical networks. Nat Rev Neurosci (2002) 3.13
Melanized dopaminergic neurons are differentially susceptible to degeneration in Parkinson's disease. Nature (1988) 3.12
Synaptic adhesion molecules. Curr Opin Cell Biol (2003) 2.74
It could be habit forming: drugs of abuse and striatal synaptic plasticity. Trends Neurosci (2003) 2.44
Reduced prefrontal activity predicts exaggerated striatal dopaminergic function in schizophrenia. Nat Neurosci (2002) 2.32
Motor neuron-derived retinoid signaling specifies the subtype identity of spinal motor neurons. Cell (1998) 1.94
Synaptopodin-deficient mice lack a spine apparatus and show deficits in synaptic plasticity. Proc Natl Acad Sci U S A (2003) 1.79
Caspase-3 dependent proteolytic activation of protein kinase C delta mediates and regulates 1-methyl-4-phenylpyridinium (MPP+)-induced apoptotic cell death in dopaminergic cells: relevance to oxidative stress in dopaminergic degeneration. Eur J Neurosci (2003) 1.49
The dopamine-containing neuron: maestro or simple musician in the orchestra of addiction? Trends Pharmacol Sci (2003) 1.39
Hyperprolactinemia: etiology, diagnosis, and management. Semin Reprod Med (2002) 1.34
Induction of the learning and plasticity-associated gene Zif268 following exposure to a discrete cocaine-associated stimulus. Eur J Neurosci (2003) 1.31
Dieldrin induces apoptosis by promoting caspase-3-dependent proteolytic cleavage of protein kinase Cdelta in dopaminergic cells: relevance to oxidative stress and dopaminergic degeneration. Neuroscience (2003) 1.30
Involvement of cyclic GMP and protein kinase G in the regulation of apoptosis and survival in neural cells. Neurosignals (2002) 1.26
Parkinson's disease: loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology (1985) 1.24
Noradrenergic neurons in the zebrafish hindbrain are induced by retinoic acid and require tfap2a for expression of the neurotransmitter phenotype. Development (2003) 1.18
PACAP protects cerebellar granule neurons against oxidative stress-induced apoptosis. Eur J Neurosci (2002) 1.16
Phospholipase Cgamma in distinct regions of the ventral tegmental area differentially modulates mood-related behaviors. J Neurosci (2003) 1.15
Specification of distinct dopaminergic neural pathways: roles of the Eph family receptor EphB1 and ligand ephrin-B2. J Neurosci (1999) 1.10
Delayed mesolimbic system alteration in a developmental animal model of schizophrenia. J Neurosci (2002) 1.07
Dlx transcription factors regulate differentiation of dopaminergic neurons of the ventral thalamus. Mol Cell Neurosci (2003) 1.04
Neurotrophic and neuroprotective effects of pituitary adenylate cyclase-activating polypeptide (PACAP) on mesencephalic dopaminergic neurons. J Neurosci Res (1998) 1.02
The coupling of a trkB tyrosine residue to LTP. Trends Neurosci (2003) 1.00
Behavioural, pharmacological, morpho-functional molecular studies reveal a hyperfunctioning mesocortical dopamine system in an animal model of attention deficit and hyperactivity disorder. Neurosci Biobehav Rev (2003) 0.98
Chronic MPTP treatment reproduces in baboons the differential vulnerability of mesencephalic dopaminergic neurons observed in Parkinson's disease. Neuroscience (1994) 0.93
Mice overexpressing extracellular superoxide dismutase have increased resistance to global cerebral ischemia. Exp Neurol (2000) 0.90
Lipoprotein lipase affects the survival and differentiation of neural cells exposed to very low density lipoprotein. J Biol Chem (2002) 0.90
Regulation of the tyrosine hydroxylase and dopamine beta-hydroxylase genes by the transcription factor AP-2. J Neurochem (2001) 0.89
Reduction of zif268 messenger RNA expression during prolonged withdrawal following "binge" cocaine self-administration in rats. Neuroscience (2000) 0.88
Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J Neurobiol (1999) 0.88
Zinc-induced apoptosis in substantia nigra of rat brain: neuroprotection by vitamin D3. Free Radic Biol Med (2003) 0.87
Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Ann Neurol (1985) 0.86
Evidence for the pro-oxidant effect of gamma-glutamyltranspeptidase-related enzyme. Free Radic Biol Med (2000) 0.85
A novel gene overexpressed in the prostate of castrated rats: hormonal regulation, relationship to apoptosis and to acquired prostatic cell androgen independence. Endocrinology (1999) 0.84
Monoaminergic synapses and schizophrenia: 45 years of neuroleptics. J Psychopharmacol (1998) 0.82
Mesolimbic dopaminergic neurons are not spared by MPTP neurotoxicity in mice. Eur J Pharmacol (1985) 0.81
Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts. Neurosci Lett (1999) 0.81
MPTP treatment combined with ethanol or acetaldehyde selectively destroys dopaminergic neurons in mouse substantia nigra. Brain Res (1989) 0.79
Decreased number of oxytocin-immunoreactive neurons in the paraventricular nucleus of the hypothalamus in Parkinson's disease. Neurology (1994) 0.79
Use of florbetapir-PET for imaging beta-amyloid pathology. JAMA (2011) 6.92
Gabapentin receptor alpha2delta-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell (2009) 3.46
Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat Rev Microbiol (2004) 3.23
Passive immunotherapy against Abeta in aged APP-transgenic mice reverses cognitive deficits and depletes parenchymal amyloid deposits in spite of increased vascular amyloid and microhemorrhage. J Neuroinflammation (2004) 2.67
Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med (2009) 2.51
Passive amyloid immunotherapy clears amyloid and transiently activates microglia in a transgenic mouse model of amyloid deposition. J Neurosci (2004) 2.38
Novel class of pain drugs based on antagonism of NGF. Trends Pharmacol Sci (2005) 2.06
Deglycosylated anti-amyloid-beta antibodies eliminate cognitive deficits and reduce parenchymal amyloid with minimal vascular consequences in aged amyloid precursor protein transgenic mice. J Neurosci (2006) 1.79
Microglial activation facilitates Abeta plaque removal following intracranial anti-Abeta antibody administration. Neurobiol Dis (2004) 1.73
The netrin-G1 ligand NGL-1 promotes the outgrowth of thalamocortical axons. Nat Neurosci (2003) 1.66
Neurons expressing the highest levels of gamma-synuclein are unaffected by targeted inactivation of the gene. Mol Cell Biol (2003) 1.53
Gata2 specifies serotonergic neurons downstream of sonic hedgehog. Development (2004) 1.34
Phosphorylation-independent effects of CagA during interaction between Helicobacter pylori and T84 polarized monolayers. J Infect Dis (2004) 1.32
Nerve growth factor mediates hyperalgesia and cachexia in auto-immune arthritis. Pain (2005) 1.20
TrkB agonists ameliorate obesity and associated metabolic conditions in mice. Endocrinology (2007) 1.16
Loss of Hspa9b in zebrafish recapitulates the ineffective hematopoiesis of the myelodysplastic syndrome. Blood (2005) 1.16
Zinc finger protein too few controls the development of monoaminergic neurons. Nat Neurosci (2003) 1.15
Effect of water/fuel emulsions and a cerium-based combustion improver additive on HD and LD diesel exhaust emissions. Environ Sci Technol (2005) 1.09
Correlation of amyloid PET ligand florbetapir F 18 binding with Aβ aggregation and neuritic plaque deposition in postmortem brain tissue. Alzheimer Dis Assoc Disord (2012) 1.08
Prostaglandin E2 prevents Helicobacter-induced gastric preneoplasia and facilitates persistent infection in a mouse model. Gastroenterology (2009) 1.05
Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent. Semin Nucl Med (2011) 1.01
Intracranial administration of deglycosylated C-terminal-specific anti-Abeta antibody efficiently clears amyloid plaques without activating microglia in amyloid-depositing transgenic mice. J Neuroinflammation (2006) 0.97
Caspase inhibitors attenuate 1-methyl-4-phenylpyridinium toxicity in primary cultures of mesencephalic dopaminergic neurons. J Neurosci (2002) 0.95
Appetite enhancement and weight gain by peripheral administration of TrkB agonists in non-human primates. PLoS One (2008) 0.92
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol (2013) 0.92
A direct role of the homeodomain proteins Phox2a/2b in noradrenaline neurotransmitter identity determination. J Neurochem (2002) 0.91
Multimodal image coregistration and inducible selective cell ablation to evaluate imaging ligands. Proc Natl Acad Sci U S A (2011) 0.90
Suppression of amyloid deposition leads to long-term reductions in Alzheimer's pathologies in Tg2576 mice. J Neurosci (2009) 0.89
Multidentate (18)F-polypegylated styrylpyridines as imaging agents for Aβ plaques in cerebral amyloid angiopathy (CAA). J Med Chem (2011) 0.86
Deglycosylated anti-Abeta antibody dose-response effects on pathology and memory in APP transgenic mice. J Neuroimmune Pharmacol (2008) 0.85
Molecular mechanisms controlling the development of dopaminergic neurons. Semin Cell Dev Biol (2003) 0.84
Gene biomarkers in diatom Thalassiosira pseudonana exposed to polycyclic aromatic hydrocarbons from contaminated marine surface sediments. Aquat Toxicol (2010) 0.83
Impact of polyelectrolytes and their corresponding multilayers to human primary endothelial cells. J Biomater Appl (2012) 0.80
Treatment with trkC agonist antibodies delays disease progression in neuromuscular degeneration (nmd) mice. Hum Mol Genet (2005) 0.79
Effects of the combination of metyrapone and oxazepam on cocaine craving and cocaine taking: a double-blind, randomized, placebo-controlled pilot study. J Psychopharmacol (2012) 0.78
Occurrence of polychlorinated dibenzo-p-dioxins and dibenzofurans (PCDD/Fs), polychlorinated biphenyls (PCBs) and polybrominated diphenyl ethers (PBDEs) in Lake Maggiore (Italy and Switzerland). J Environ Monit (2007) 0.76
Conformation as the Therapeutic Target for Neurodegenerative Diseases. Curr Alzheimer Res (2017) 0.75
Chronological age impacts immunotherapy and monocyte uptake independent of amyloid load. J Neuroimmune Pharmacol (2011) 0.75